Your browser doesn't support javascript.
loading
A distributable LC-MS/MS method for the measurement of serum thyroglobulin.
Shi, Junyan; Phipps, William S; Owusu, Benjamin Y; Henderson, Clark M; Laha, Thomas J; Becker, Jessica O; Razavi, Morteza; Emrick, Michelle A; Hoofnagle, Andrew N.
Afiliação
  • Shi J; Departments of Laboratory Medicine and Pathology, USA.
  • Phipps WS; Departments of Laboratory Medicine and Pathology, USA.
  • Owusu BY; Departments of Laboratory Medicine and Pathology, USA.
  • Henderson CM; Departments of Laboratory Medicine and Pathology, USA.
  • Laha TJ; Departments of Laboratory Medicine and Pathology, USA.
  • Becker JO; Departments of Laboratory Medicine and Pathology, USA.
  • Razavi M; SISCAPA Assay Technologies, Inc, Washington, DC, USA.
  • Emrick MA; Departments of Laboratory Medicine and Pathology, USA.
  • Hoofnagle AN; Departments of Laboratory Medicine and Pathology, USA.
J Mass Spectrom Adv Clin Lab ; 26: 28-33, 2022 Nov.
Article em En | MEDLINE | ID: mdl-36388059
Background: Despite its clear advantages over immunoassay-based testing, the measurement of serum thyroglobulin by mass spectrometry remains limited to a handful of institutions. Slow adoption by clinical laboratories could reflect limited accessibility to existing methods that have sensitivity comparable to modern immunoassays, as well as a lack of tools for calibration and assay harmonization. Methods: We developed and validated a liquid chromatography-tandem mass spectrometry-based assay for the quantification of serum thyroglobulin. The protocol combined peptide immunoaffinity purification using a commercially available, well-characterized monoclonal antibody and mobile phase modification with dimethylsulfoxide (DMSO) for enhanced sensitivity. To facilitate harmonization with other laboratories, we developed a novel, serum-based 5-point distributable reference material (Husky Ref). Results: The assay demonstrated a lower limit of quantification of 0.15 ng/mL (<20 %CV). Mobile phase DMSO increased signal intensity of the target peptide at least 3-fold, improving quantification at low concentrations. Calibration traceable to Husky Ref enabled harmonization between laboratories in an interlaboratory study. Conclusions: Sensitive mass spectrometry-based thyroglobulin measurement can be achieved using a monoclonal antibody during peptide immunoaffinity purification and the addition of mobile phase DMSO. Laboratories interested in deploying this assay can utilize the provided standard operating procedure and freely-available Husky Ref reference material.
Palavras-chave

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Revista: J Mass Spectrom Adv Clin Lab Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Revista: J Mass Spectrom Adv Clin Lab Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos